Novo Nordisk
Monday, June 03, 2024
Company Presentation
Metabolic Diseases
Company Presentation Theater 2
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, chronic cardiovascular disease and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 47,000 people in 80 offices around the world and markets its products in around 168 countries.
){kind=logo}
Company Website:
http://www.novonordisk.com
Lead Product in Development:
https://www.novonordisk.com/science-and-technology/r-d-pipeline.html
Number Of Unlicensed Products (For Which You Are Seeking Partners):
N/A
Exchange
NYSE
Ticker
NVO
Company HQ City
Copenhagen
Company HQ State
N/A
Company HQ Country
Denmark
CEO/Top Company Official
Lars Fruergaard Jørgensen
Development Phase of Primary Product
Other/Not Applicable
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())